Baku, Azerbaijan, August 15
By Fakhri Vakilov - Trend:
A site for the production of carbapenems (antibiotics) will be created in Yunusabad region of Tashkent, within the framework of agreements between Uzbekistan and Belarus, Trend reports referring to a decree of the Cabinet of Ministers of Uzbekistan.
It states that buildings and structures with a total area of 14,625 sq. m at the “zero” redemption value on a site of 2 hectares will be transferred to the Belfarm foreign enterprise.
The decree provides that the investor (Belfarm) must fulfill the investment and social obligations within five years. The company must attract foreign direct investment in the equivalent of at least $10 million.
The company plans to produce sterile antibiotic powders (10 million vials per year), solid dosage forms (500 million tablets, 60 million capsules and 6 million sachets per year) in accordance with Good Manufacturing Practice (GMP).
The investor must create at least 120 jobs.
---
Follow author on Twitter:@vakilovfaxri